International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 (full – 2010)http://pharmrev.aspetjournals.org/co....full.pdf+html
A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans (full – 2011) http://joe.endocrinology-journals.or...211/2/177.long
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents (full – 2011)http://onlinelibrary.wiley.com/doi/1...1.01742.x/full
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents (full – 2011)http://onlinelibrary.wiley.com/doi/1...1.01742.x/full
The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55 (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21683763
The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116968/
The atypical cannabinoid O-1602 shows antitumorigenic effects in colon cancer cells and reduces tumor growth in a colitis-associated colon cancer model (full – 2012) http://www.biomedcentral.com/content...-13-S1-A23.pdf
GPR18 in microglia: implications for the CNS and endocannabinoid system signaling (full – 2012)http://onlinelibrary.wiley.com/doi/1...2.02019.x/full
Evidence for the Putative Cannabinoid Receptor (GPR55)-Mediated Inhibitory Effects on Intestinal Contractility in Mice (full – 2012)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548934/
siRNA knockdown of GPR18 receptors in BV-2 microglia attenuates N-arachidonoyl glycine-induced cell migration (full – 2012)http://www.jmolecularsignaling.com/content/7/1/10
The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21981246
The atypical cannabinoid O-1602 increases hind paw sensitisation in the chronic constriction injury model of neuropathic pain (abst – 2012)http://www.ncbi.nlm.nih.gov/pubmed/22227298
The Atypical Cannabinoid O-1602: Targets, Actions, and the Central Nervous System (abst – 2012)http://www.ncbi.nlm.nih.gov/pubmed/22831390
O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms (full – 2013)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529923/
Role of endogenous cannabinoid system in the gut (full – 2013) http://www.actaps.com.cn/qikan/manag.../2013-4-12.pdf
A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice (full – 2013)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677091/
A GPR18-based signaling system regulates IOP in murine eye (full– 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687663/
Regulation of cell proliferation by GPR55/cannabinoid receptors using (R,R')-4’-methoxy-1-naphthylfenoterol in rat C6 glioma cell line (abst – 2013) http://www.abstractsonline.com/Plan/...9-07c21f6e9bc9
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/22850623
(R,R’)-4’-methoxy-1-naphthylfenoterol Inhibits GPR55 signaling and the modulation of motility in human cancer cells (abst – 2013)http://www.abstractsonline.com/Plan/...9-07c21f6e9bc9
Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23992544
Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24030360
Anticancer activity of anandamide in human cutaneous melanoma cells (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24041928
Increase of mesenchymal stem cell migration by Cannabidiol via activation of p42/44 MAPK (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24304686
(R,R')-4'-Methoxy-1-naphthylfenoterol Targets GPR55-mediated Ligand Internalization and Impairs Cancer Cell Motility (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24355564
Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24467410
Activation of GPR18 by Cannabinoid compounds: A tale of biased agonism (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24762058
A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans (full – 2011) http://joe.endocrinology-journals.or...211/2/177.long
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents (full – 2011)http://onlinelibrary.wiley.com/doi/1...1.01742.x/full
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents (full – 2011)http://onlinelibrary.wiley.com/doi/1...1.01742.x/full
The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55 (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21683763
The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116968/
The atypical cannabinoid O-1602 shows antitumorigenic effects in colon cancer cells and reduces tumor growth in a colitis-associated colon cancer model (full – 2012) http://www.biomedcentral.com/content...-13-S1-A23.pdf
GPR18 in microglia: implications for the CNS and endocannabinoid system signaling (full – 2012)http://onlinelibrary.wiley.com/doi/1...2.02019.x/full
Evidence for the Putative Cannabinoid Receptor (GPR55)-Mediated Inhibitory Effects on Intestinal Contractility in Mice (full – 2012)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548934/
siRNA knockdown of GPR18 receptors in BV-2 microglia attenuates N-arachidonoyl glycine-induced cell migration (full – 2012)http://www.jmolecularsignaling.com/content/7/1/10
The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21981246
The atypical cannabinoid O-1602 increases hind paw sensitisation in the chronic constriction injury model of neuropathic pain (abst – 2012)http://www.ncbi.nlm.nih.gov/pubmed/22227298
The Atypical Cannabinoid O-1602: Targets, Actions, and the Central Nervous System (abst – 2012)http://www.ncbi.nlm.nih.gov/pubmed/22831390
O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms (full – 2013)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529923/
Role of endogenous cannabinoid system in the gut (full – 2013) http://www.actaps.com.cn/qikan/manag.../2013-4-12.pdf
A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice (full – 2013)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677091/
A GPR18-based signaling system regulates IOP in murine eye (full– 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687663/
Regulation of cell proliferation by GPR55/cannabinoid receptors using (R,R')-4’-methoxy-1-naphthylfenoterol in rat C6 glioma cell line (abst – 2013) http://www.abstractsonline.com/Plan/...9-07c21f6e9bc9
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/22850623
(R,R’)-4’-methoxy-1-naphthylfenoterol Inhibits GPR55 signaling and the modulation of motility in human cancer cells (abst – 2013)http://www.abstractsonline.com/Plan/...9-07c21f6e9bc9
Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23992544
Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24030360
Anticancer activity of anandamide in human cutaneous melanoma cells (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24041928
Increase of mesenchymal stem cell migration by Cannabidiol via activation of p42/44 MAPK (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24304686
(R,R')-4'-Methoxy-1-naphthylfenoterol Targets GPR55-mediated Ligand Internalization and Impairs Cancer Cell Motility (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24355564
Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24467410
Activation of GPR18 by Cannabinoid compounds: A tale of biased agonism (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24762058